COAG
Hemab Therapeutics Holdings, Inc.
Latest Form 4:Purchase$153KbyRA CAPITAL MANAGEMENT, L.P. (10% Owner) · filed Jun 17, 2026
Hemab Therapeutics Holdings, Inc. (COAG) has 7 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 17, 2026.
The most active filer is 10% Owner RA CAPITAL MANAGEMENT, L.P. with 11 filings. Insiders have net bought $55.5M over the trailing 6 months. The largest single insider purchase in this window was $48.1M by Director, 10% Owner RA CAPITAL MANAGEMENT, L.P. on May 4, 2026.
- Industry:Biotechnology
- CEO:Benny Sorensen
- Employees:59
- HQ:Cambridge, MA, US
- IPO:2026-05-01
Insider Buying
$55.5M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$2.1B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| 10% Owner | Purchase | 6,146 | $153K | Jun 17 | SEC ↗ | |
| 10% Owner | Purchase | 61,523 | $1.5M | Jun 17 | SEC ↗ | |
| 10% Owner | Purchase | 3,802 | $95K | May 21 | SEC ↗ | |
| 10% Owner | Purchase | 996 | $25K | May 21 | SEC ↗ | |
| 10% Owner | Purchase | 6,387 | $159K | May 14 | SEC ↗ | |
| 10% Owner | Purchase | 9,906 | $242K | May 11 | SEC ↗ | |
| 10% Owner | Purchase | 1,483 | $37K | May 11 | SEC ↗ | |
| 10% Owner | Purchase | 39,869 | $989K | May 11 | SEC ↗ | |
| Director, 10% Owner | Purchase | 2,675,000 | $48.1M | May 6 | SEC ↗ | |
| Director, 10% Owner | Purchase | 97,411 | $2.4M | May 6 | SEC ↗ | |
| Director, 10% Owner | Purchase | 68,018 | $1.7M | May 6 | SEC ↗ |
Related companies
Hemab Therapeutics Holdings, Inc. is in the Healthcare sector.